Diffuse Large B-Cell Lymphoma Market, Size, Share, Trends, Epidemiology Forecast till 2030

September 01 12:17 2020
Diffuse Large B-Cell Lymphoma Market, Size, Share, Trends, Epidemiology Forecast till 2030

DelveInsight Business Research LLP
DelveInsight’s ” Diffuse Large B-cell Lymphoma Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Diffuse Large B-cell Lymphoma, historical and forecasted epidemiology as well as the Diffuse Large B-cell Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) that affects B-lymphocytes. It develops when B-lymphocytes become abnormal. It is a mature B-cell neoplasm arising from the germinal center and post germinal center B-cells.

 

Diffuse Large B-Cell Lymphoma Market Insight

Diffuse Large B-Cell Lymphoma market Size in 7MM was USD 2,692 million in 2017. 

Diffuse Large B-cell Lymphoma Market Outlook

The Diffuse Large B-cell Lymphoma market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Diffuse Large B-cell Lymphoma market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. 

This segment gives a thorough detail of Diffuse Large B-cell Lymphoma market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight. 

According to DelveInsight, Diffuse Large B-cell Lymphoma market in 7MM is expected to change in the study period 2017-2030.

Diffuse Large B-Cell Lymphoma Market Drivers

  • Rising Incidence among Aging population
  • Increase in R&D
  • CAR-T therapies approvals

Diffuse Large B-Cell Lymphoma Market Barriers

  • Availability of defined diagnostic tools
  • Delay in Diagnosis
  • High cost of treatment

Request for sample pages
Table of contents

1. Key Insights

2. Executive Summary of Diffuse Large B-cell Lymphoma

3. Competitive Intelligence Analysis for Diffuse Large B-cell Lymphoma

4. Diffuse Large B-cell Lymphoma: Market Overview at a Glance

4.1. Diffuse Large B-cell Lymphoma Total Market Share (%) Distribution in 2017

4.2. Diffuse Large B-cell Lymphoma Total Market Share (%) Distribution in 2030

5. Diffuse Large B-cell Lymphoma: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms 

5.3. Pathophysiology 

5.4. Risk Factors 

5.5. Diagnosis 

6. Patient Journey

7. Diffuse Large B-cell Lymphoma Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Diffuse Large B-cell Lymphoma Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Diffuse Large B-cell Lymphoma Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Diffuse Large B-cell Lymphoma Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Diffuse Large B-cell Lymphoma Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Diffuse Large B-cell Lymphoma Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Diffuse Large B-cell Lymphoma Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Diffuse Large B-cell Lymphoma Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Diffuse Large B-cell Lymphoma Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Diffuse Large B-cell Lymphoma Treatment and Management

8.2. Diffuse Large B-cell Lymphoma Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Diffuse Large B-cell Lymphoma Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Diffuse Large B-cell Lymphoma: Seven Major Market Analysis

13.1. Key Findings

13.2. Diffuse Large B-cell Lymphoma Market Size in 7MM

13.3. Diffuse Large B-cell Lymphoma Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Diffuse Large B-cell Lymphoma Total Market Size in the United States

15.1.2. Diffuse Large B-cell Lymphoma Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Diffuse Large B-cell Lymphoma Total Market Size in Germany

15.3.2. Diffuse Large B-cell Lymphoma Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Diffuse Large B-cell Lymphoma Total Market Size in France

15.4.2. Diffuse Large B-cell Lymphoma Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Diffuse Large B-cell Lymphoma Total Market Size in Italy

15.5.2. Diffuse Large B-cell Lymphoma Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Diffuse Large B-cell Lymphoma Total Market Size in Spain

15.6.2. Diffuse Large B-cell Lymphoma Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Diffuse Large B-cell Lymphoma Total Market Size in the United Kingdom

15.7.2. Diffuse Large B-cell Lymphoma Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Diffuse Large B-cell Lymphoma Total Market Size in Japan

15.8.3. Diffuse Large B-cell Lymphoma Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Diffuse Large B-cell Lymphoma

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

  Categories: